思维的转变：基于细胞热位移分析的药物发现
A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery.
作者信息
Caballero Isabel Martín, Lundgren Stina
机构信息
Pelago Bioscience AB, 17165 Solna, Sweden.
出版信息
ACS Med Chem Lett. 2023 Mar 17;14(4):369-375. doi: 10.1021/acsmedchemlett.2c00545. eCollection 2023 Apr 13.
Abstract
A decade has passed since the cellular thermal shift assay (CETSA) was introduced to the drug discovery community. Over the years, the method has guided numerous projects by providing insights about, for example, target engagement, lead generation, target identification, lead optimization, and preclinical profiling. With this Microperspective, we intend to highlight recently published applications of CETSA and how the data generated can enable efficient decision-making and prioritization throughout the drug discovery and development value chain.
摘要
细胞热位移分析（CETSA）被引入药物研发领域已有十年。多年来，该方法通过提供有关靶点结合、先导化合物生成、靶点鉴定、先导化合物优化和临床前分析等方面的见解，指导了众多项目。通过这篇微观视角文章，我们旨在突出CETSA最近发表的应用，以及所生成的数据如何在整个药物研发和开发价值链中实现高效决策和优先级排序。
相似文献
1
A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery.思维的转变：基于细胞热位移分析的药物发现
ACS Med Chem Lett. 2023 Mar 17;14(4):369-375. doi: 10.1021/acsmedchemlett.2c00545. eCollection 2023 Apr 13.
2
CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products.CETSA 和热蛋白质组学分析策略在天然产物的靶标鉴定和药物发现中的应用。
Phytomedicine. 2023 Jul 25;116:154862. doi: 10.1016/j.phymed.2023.154862. Epub 2023 May 20.
3
Cellular thermal shift assay: an approach to identify and assess protein target engagement.细胞热转移分析：一种鉴定和评估蛋白靶标结合的方法。
Expert Rev Proteomics. 2024 Sep-Oct;21(9-10):387-400. doi: 10.1080/14789450.2024.2406785. Epub 2024 Sep 29.
4
The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies.细胞热转移分析：一种用于药物靶标原位结合及机制生物标志物研究的新型生物物理分析方法。
Annu Rev Pharmacol Toxicol. 2016;56:141-61. doi: 10.1146/annurev-pharmtox-010715-103715. Epub 2015 Nov 9.
5
High-Throughput Cellular Thermal Shift Assays in Research and Drug Discovery.高通量细胞热转移分析在研究和药物发现中的应用。
SLAS Discov. 2020 Feb;25(2):137-147. doi: 10.1177/2472555219877183. Epub 2019 Sep 30.
6
Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1.通过针对 B-Raf 和 PARP1 的筛选，将高通量 CETSA 定位在早期药物发现中。
SLAS Discov. 2019 Feb;24(2):121-132. doi: 10.1177/2472555218813332. Epub 2018 Dec 13.
7
Focusing on Relevance: CETSA-Guided Medicinal Chemistry and Lead Generation.聚焦相关性：基于细胞热位移分析技术指导的药物化学与先导化合物发现
ACS Med Chem Lett. 2019 Apr 5;10(5):690-693. doi: 10.1021/acsmedchemlett.9b00112. eCollection 2019 May 9.
8
Perspective on CETSA Literature: Toward More Quantitative Data Interpretation.CETSA 文献透视：迈向更定量数据解读。
SLAS Discov. 2020 Feb;25(2):118-126. doi: 10.1177/2472555219884524. Epub 2019 Oct 30.
9
Real-Time Cellular Thermal Shift Assay to Monitor Target Engagement.实时细胞热转移分析监测靶标结合。
ACS Chem Biol. 2022 Sep 16;17(9):2471-2482. doi: 10.1021/acschembio.2c00334. Epub 2022 Sep 1.
10
A High-Throughput Dose-Response Cellular Thermal Shift Assay for Rapid Screening of Drug Target Engagement in Living Cells, Exemplified Using SMYD3 and IDO1.高通量剂量反应细胞热转移分析用于快速筛选活细胞中的药物靶标结合，以 SMYD3 和 IDO1 为例。
SLAS Discov. 2018 Jan;23(1):34-46. doi: 10.1177/2472555217732014. Epub 2017 Sep 28.
引用本文的文献
1
Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1.发现一种硝基芳香族纳曲酮，通过靶向 AKT1 对结直肠癌具有强大的体内抗癌活性。
Acta Pharmacol Sin. 2024 May;45(5):1044-1059. doi: 10.1038/s41401-024-01231-w. Epub 2024 Feb 7.
2
Modular Nanotransporters Delivering Biologically Active Molecules to the Surface of Mitochondria.模块化纳米转运体将生物活性分子递送至线粒体表面
Pharmaceutics. 2023 Nov 27;15(12):2687. doi: 10.3390/pharmaceutics15122687.
本文引用的文献
1
Nonionic Surfactants can Modify the Thermal Stability of Globular and Membrane Proteins Interfering with the Thermal Proteome Profiling Principles to Identify Protein Targets.非离子表面活性剂可以改变球状和膜蛋白的热稳定性，干扰热蛋白质组分析原理，从而识别蛋白质靶标。
Anal Chem. 2023 Feb 28;95(8):4033-4042. doi: 10.1021/acs.analchem.2c04500. Epub 2023 Feb 13.
2
High throughput screening of 0.5 million compounds against CRAF using Alpha CETSA.使用 Alpha CETSA 对 50 万种化合物进行 CRAF 的高通量筛选。
SLAS Discov. 2023 Apr;28(3):102-110. doi: 10.1016/j.slasd.2023.01.006. Epub 2023 Feb 1.
3
Discovery of 3-Amino-1-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family.发现基于 3-氨基-1-吡唑的激酶抑制剂，以阐明研究不足的 PCTAIRE 家族。
Int J Mol Sci. 2022 Nov 27;23(23):14834. doi: 10.3390/ijms232314834.
4
Advancing New Chemical Modalities into Clinical Studies.推进新型化学药物进入临床研究。
ACS Med Chem Lett. 2022 Oct 27;13(11):1691-1698. doi: 10.1021/acsmedchemlett.2c00375. eCollection 2022 Nov 10.
5
Phenotypic drug discovery: recent successes, lessons learned and new directions.表型药物发现：近期的成功、经验教训和新方向。
Nat Rev Drug Discov. 2022 Dec;21(12):899-914. doi: 10.1038/s41573-022-00472-w. Epub 2022 May 30.
6
Proteome-wide cellular thermal shift assay reveals unexpected cross-talk between brassinosteroid and auxin signaling.蛋白质组细胞热转移分析揭示了油菜素内酯和生长素信号之间意想不到的串扰。
Proc Natl Acad Sci U S A. 2022 Mar 15;119(11):e2118220119. doi: 10.1073/pnas.2118220119. Epub 2022 Mar 7.
7
Kurarinone alleviated Parkinson's disease via stabilization of epoxyeicosatrienoic acids in animal model.槐定碱通过稳定环氧二十碳三烯酸在动物模型中缓解帕金森病。
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9). doi: 10.1073/pnas.2118818119.
8
Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.一种小分子二硫键还原酶抑制剂的特性研究，该抑制剂可诱导肺癌细胞发生氧化应激并导致其死亡。
Cell Rep. 2022 Feb 8;38(6):110343. doi: 10.1016/j.celrep.2022.110343.
9
Mechanistic Insights into a CDK9 Inhibitor Via Orthogonal Proteomics Methods.通过正交蛋白质组学方法深入了解 CDK9 抑制剂的作用机制。
ACS Chem Biol. 2022 Jan 21;17(1):54-67. doi: 10.1021/acschembio.1c00488. Epub 2021 Dec 25.
10
In Pursuit of an Allosteric Human Tropomyosin Kinase A (TrkA) Inhibitor for Chronic Pain.寻找用于慢性疼痛的变构人原肌球蛋白受体激酶A（TrkA）抑制剂。
ACS Med Chem Lett. 2021 Oct 25;12(11):1847-1852. doi: 10.1021/acsmedchemlett.1c00483. eCollection 2021 Nov 11.
Zotero 插件